UnitedHealth Group lifts quarterly dividend by 5% as Q1 earnings beat estimates

UnitedHealth Group has announced a 5% increase in its quarterly dividend, raising the payout from $2.21 to $2.32 per share. This decision marks the company’s 16th consecutive year of dividend growth, signalling management’s confidence in its financial position. The next payment is scheduled for distribution on June 23.

The announcement follows a robust first-quarter performance for calendar 2026. UnitedHealth reported revenue of $111.7 billion, representing a 2% year-on-year increase and surpassing analyst estimates by $1.9 billion. Adjusted earnings per share came in at $7.23, beating consensus figures by 9.4%. The company also reported adjusted EBITDA of $9.99 billion with an 8.9% margin, which was 5.1% above expectations.

Management cited strong cash flow generation as a key driver for the dividend hike. Free cash flow margin improved significantly to 7.3%, up from 4.2% a year earlier, providing additional capacity to support shareholder returns. However, operating cash flow was reported at $8.9 billion, marking a 54.75% decrease year-on-year.

The dividend increase occurs against a backdrop of rising global health insurance costs. According to WTW’s 2026 Global Medical Trends report, costs are expected to rise by an average of 10.3% this year, following increases of 10% in 2025 and 9.5% in 2024. Despite this pressure on insurer margins, UnitedHealth’s stock closed at $398 on Thursday, up 20.8% year-to-date.

In parallel with its financial updates, UnitedHealth is implementing operational changes across its UnitedHealthcare and Optum segments. The insurer is eliminating most medical prior authorisations and committing to a 30% reduction in overall requirements. Additionally, the Optum Rx segment has introduced a transparent pharmacy care model, while the company has expanded doula offerings to employer-sponsored plans nationwide.

Analyst sentiment remains positive, with a survey of 26 analysts showing a “Strong Buy” consensus and an average price target of $403.92. Piper Sandler analyst Jessica Tassan recently raised her price target to $420. The next earnings update for the quarter ending June 2026 is scheduled for August 4, with the average earnings estimate at $4.84 per share.